Inadequate antimicrobial prophylaxis during surgery: A study of β-lactam levels during burn debridement

13Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Objectives: To determine how long single-dose prophylactic antibiotic regimens for burns surgery maintained plasma concentrations above the MICs for target organisms during surgery. Patients and methods: We monitored antibiotic plasma concentrations in 12 patients (mean ± SD 43 ± 12% total burn surface area) throughout debridement surgery after administration of the standard prophylactic antibiotic dosing regimens of either 1 g of intravenous cefalotin or 4.5 g of intravenous piperacillin/tazobactam. Results: The eschar debridement and grafting procedures ranged in duration from 2.25 to over 8.5 h. The duration of total plasma cefalotin concentration above an MIC of 0.2 mg/L for Staphylococcus aureus was 6.49 ± 2.85 h, whereas the mean duration of total plasma piperacillin concentration above an MIC of 64 mg/L for Pseudomonas aeruginosa was only 1.15 ± 0.59 h. None of the patients dosed with piperacillin/tazobactam was adequately protected for the duration of their surgery and adequate prophylaxis was only evident in four of the nine patients administered cefalotin. Conclusions: These results suggest a need to review antibiotic prophylaxis dosage regimens for burns surgery and the adoption of regimens that will minimize the risk of infection in this high-risk patient group. It is suggested that the antibiotic prophylaxis guideline for burn debridement surgery be modified to include re-dosing or a continuous infusion of β-lactam antibiotics. © The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.

Cite

CITATION STYLE

APA

Dalley, A. J., Lipman, J., Venkatesh, B., Rudd, M., Roberts, M. S., & Cross, S. E. (2007). Inadequate antimicrobial prophylaxis during surgery: A study of β-lactam levels during burn debridement. Journal of Antimicrobial Chemotherapy, 60(1), 166–169. https://doi.org/10.1093/jac/dkm128

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free